Study design A retrospective cohort study will be conducted to compare the efficacy and safety of citrate anticoagulation in CRRT among patients with liver failure/dysfunction and severe shock.
Objectives
1. Primary Objective: To determine if the etiology of liver failure impacts the incidence of citrate-related complications in patients undergoing CRRT. 2. Secondary Objectives: To compare the efficacy of citrate anticoagulation in terms of renal recovery, filter lifespan, and patient survival between those with liver failure/dysfunction and severe shock.
Critically ill patients diagnosed with AKI requiring CRRT. Caution Protocol V1.0 24-07-2024
Documented liver failure or significant liver dysfunction (e.g., elevated liver enzymes, bilirubin levels, or clinical diagnosis of liver failure) and clincal diagnosis of shock (NE of 0.25 μg/kg/min and or association of second vasopressor).
Age ≥ 18 years.
NA
Critically ill patients diagnosed with AKI requiring CRRT
Case-only
Retrospective
Not listed
Primary Safety Endpoint:
Incidence of citrate-related metabolic complications (e.g., citrate accumulation).
Secondary Safety Endpoints
* Incidence of electrolyte imbalances (e.g., hypocalcemia). * Incidence of adverse events related to anticoagulation.
Click on the lead sponsor to view all of their trials.
